SHE:301333 - R&G PharmaStudies Co Ltd

R&G PharmaStudies Co. Ltd. A
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2013	2014	2015	2017	2018	2019	2020	2021	2022	2023	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	0% -	69.65% -
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	16.31% -5.8%	17.79% 9.1%	22.53% 26.6%
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	38.32% -2.4%	36.85% -3.9%	39.79% 8.0%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	19.75% -6.6%	17.58% -11.0%	20.56% 17.0%
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	608.43M 25.6%	637.52M 4.8%	721.37M 13.2%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	677.47M 26.3%	1.88B 178.0%	2.07B 10.1%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	239.66M 20.2%	289.35M 20.7%	319.17M 10.3%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	422.53M 30.9%	1.59B 275.8%	1.75B 10.1%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	114.57M 159.8%	130.47M 13.9%	192.56M 47.6%
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	293.52M 7.1%	361.3M 23.1%	1.52B 321.0%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	361.3M 23.1%	1.52B 321.0%	991.48M -34.8%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	76.29M 309.7%	109.64M 43.7%	172.68M 57.5%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	100.35M 17.7%	114.13M 13.7%	162.86M 42.7%
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.381 18.8%	1.38 -0.1%	2.08 50.7%
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	26.63% -11.0%	11.29% -57.6%	9.74% -13.7%
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	16.35% -4.1%	8.86% -45.8%	8.22% -7.3%